Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
The American Journal of Clinical Nutrition|January 24, 2003
Reduced hemodynamic load and cardiac hypotrophy in patients with anorexia nervosaCarmela Romano, Marcello Chinali, Fabrizio Pasanisi, et al.Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 2, 2023
Risk evaluation of secondary malignancies after radiotherapy of breast cancer in light of the continuous development of planning techniquesSavino Cilla, Francesco Deodato, Carmela Romano, et al.Scientific Reports|January 18, 2020
Template-based automation of treatment planning in advanced radiotherapy: a comprehensive dosimetric and clinical evaluationSavino Cilla, Anna Ianiro, Carmela Romano, et al.Biomedical Physics & Engineering Express|July 20, 2022
Prediction of VMAT delivery accuracy using plan modulation complexity score and log-files analysisPietro Viola, Carmela Romano, Maurizio Craus, et al.The British Journal of Radiology|October 10, 2025
Radiomics-based explainable artificial intelligence to predict treatment response following lung stereotactic body radiation therapySavino Cilla, Carmela Romano, Gabriella Macchia, et al.Journal of the American Society of Nephrology : JASN|November 11, 2005
Left ventricular geometry in children with mild to moderate chronic renal insufficiencyMaria Chiara Matteucci, Elke Wühl, Stefano Picca, et al.Practical Radiation Oncology|June 14, 2025
Near-miss event in lung cancer radiotherapy due to a random outlier of target volumeSavino Cilla, Carmela Romano, Gabriella Macchia, et al.Frontiers in Neurology|April 4, 2024
Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander diseaseCarmela Romano, Emanuele Morena, Simona Petrucci, et al.Microorganisms|June 2, 2021
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune DiseasesRosella Mechelli, Silvia Romano, Carmela Romano, et al.Cancer Biology & Therapy|March 1, 2007
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trialGiuseppe Di Lorenzo, Riccardo Autorino, Michele De Laurentiis, et al.Pageof 9